Gene · 6900
Papers4,207
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,207
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Strategies for immortalisation of amnion-derived mesenchymal and epithelial cells. | Cell Biol Int | 2022 | 35998259 | PubTator, text mining | PubMed |
| DDX5 and DDX17-multifaceted proteins in the regulation of tumorigenesis and tumor progression. | Front Oncol | 2022 | 35992805 | PubTator, text mining | PubMed |
| The euro area's pandemic recession: A DSGE-based interpretation. | J Econ Dyn Control | 2022 | 35991509 | PubTator, text mining | PubMed |
| The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing. | Front Immunol | 2022 | 35979358 | PubTator, text mining | PubMed |
| Alternative RNA splicing in cancer: what about adult T-cell leukemia? | Front Immunol | 2022 | 35979354 | PubTator, text mining | PubMed |
| The 'sugar tax' in Bermuda: a mixed methods study of general population and key stakeholder perceptions. | BMC Public Health | 2022 | 35974346 | PubTator, text mining | PubMed |
| Combined progressive functional exercise effect on contactin-1 and contactin-2 level in mildly disabled persons with multiple sclerosis. | Mult Scler Relat Disord | 2022 | 35963206 | PubTator, text mining | PubMed |
| Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer's disease and normal physiology. | Front Cell Dev Biol | 2022 | 35959488 | PubTator, text mining | PubMed |
| HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models. | Front Immunol | 2022 | 35958554 | PubTator, text mining | PubMed |
| In vivo visualization and molecular targeting of the cardiac conduction system. | J Clin Invest | 2022 | 35951416 | PubTator, text mining | PubMed |
| Inappropriate and potentially avoidable emergency department visits of Swiss nursing home residents and their resource use: a retrospective chart-review. | BMC Geriatr | 2022 | 35948872 | PubTator, text mining | PubMed |
| Public perception of the tax on sweetened beverages in France. | Public Health Nutr | 2022 | 35942709 | PubTator, text mining | PubMed |
| Putative Candidate Drug Targets for Sarcopenia-Related Traits Identified Through Mendelian Randomization Analysis of the Blood Proteome. | Front Genet | 2022 | 35938019 | PubTator, text mining | PubMed |
| Significance of Neuronal Autoantibodies in Comparison to Infectious Etiologies among Patients Presenting with Encephalitis in a Region with a High Prevalence of Infections. | Ann Indian Acad Neurol | 2022 | 35936609 | PubTator, text mining | PubMed |
| Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia. | Front Immunol | 2022 | 35935975 | PubTator, text mining | PubMed |
| Expression Profiles and Interaction of MicroRNA and Transcripts in Response to Bovine Leukemia Virus Exposure. | Front Vet Sci | 2022 | 35928115 | PubTator, text mining | PubMed |
| Investigation of the target genes of BLV miRNAs and the expression levels of miR-B4-3p and miR-B2-5p in cattle infected with Bovine Leukemia Virus. | Vet Res Forum | 2022 | 35919847 | PubTator, text mining | PubMed |
| TAX and HBZ: hFc Ɣ 1 proteins as targets for passive immunotherapy. | Iran J Basic Med Sci | 2022 | 35911645 | PubTator, text mining | PubMed |
| Labor markets during pandemics. | J Econ Theory | 2022 | 35911604 | PubTator, text mining | PubMed |
| Drug repurposing: a systematic review on root causes, barriers and facilitators. | BMC Health Serv Res | 2022 | 35906687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6900/papers?page=35